Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

NCT04379024 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Study agent no longer available

Conditions

Focus of Study is Healthy Women at Risk for Breast Cancer

Interventions

DRUG: DUAVEE 0.45Mg-20Mg Tablet

Sponsor

Carol Fabian, MD

Collaborators

[object Object]